Led by Dr. Lillian Sung MD, PhD, members of the Sung research team focus on optimizing supportive care for children with cancer, with a specific aim to reduce acute & delayed treatment-related toxicities and improve overall quality of life.
Understanding that cancer in children and young people is different than cancer in adults, the Sung Lab focuses their research on addressing the most important clinical issues that affect children receiving intensive treatment for their cancer. These include the development of clinical practice guidelines, the development & validation of instruments relevant to symptom screening, and the implementation of interventions to reduce treatment-related symptoms, such as fatigue.
Major focuses include:
- Pediatric cancer supportive care
- Measurement of symptoms – development of the Symptom Screening in Pediatrics Tool (SSPedi) and the Children’s International Mucositis Evaluation Scale (ChIMES)
- Development of a website to promote symptom screening and access to clinical practice guidelines called Supportive care Prioritization: Assessment and Recommendations for Kids (SPARK)
- Interventions to reduce symptoms including yoga to reduce fatigue
- Optimizing management of fever and neutropenia
- Clinical practice guideline development
- Methodological foci: randomized trials, observational studies, meta-analysis, clinical practice guideline development, patient-reported outcomes, instrument development and instrument psychometric evaluation